Printer Friendly

When to use beta-blockers.

Beta-blockers are recommended for heart failure and for secondary prevention after a recent myocardial infarction (MI). Doctors should think twice before prescribing these drugs to other highrisk groups, say researchers. Adults with a remote history of MI, those with cardiovascular disease but no history of MI, and those with just cardiovascular risk factors did not seem to benefit from beta-blockers in a large observational study (N=21 860). Treatment was not associated with a lower risk of cardiovascular death, non-fatal MI or stroke in fully adjusted analyses, and the authors found no evidence of cardiovascular benefit over four years in any of the three patient groups. They did confirm a lower risk of all cardiovascular events combined in a subgroup of adults with a recent MI.

Current practice is underpinned by old evidence that accumulated before modern reperfusion therapies and cardioprotective drug protocols, say the authors. Beta-blockers may not be as effective for many patients as was previously thought. International guidelines are already being revised.

[ILLUSTRATION OMITTED]

Bangalore S, et al. JAMA 2012;308(13):1340-1349. [http://dx.doi.org/10.1001/jama.2012.12559]

COPYRIGHT 2012 South African Medical Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Abstracts
Publication:CME: Your SA Journal of CPD
Date:Nov 1, 2012
Words:185
Previous Article:Case report.
Next Article:Sports and haemophilia.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters